There is no single, unanimous “disabled people’s perspective” on whether or not we want to be cured of our disabling conditions, or on how highly we prioritize cure or medical improvement as a goal.
MENLO PARK, Calif., March 24, 2026 /PRNewswire/ -- Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today released a new report, "The 2026 State of ...